LKFT

Lakefront Biotherapeutics N.V.

Healthcare
Biotechnology
$1.77B market cap

Forecast run · Sep 14, 2026Upside rank 2205 of 3,136

Model Signal

ForecastQ Daily Probabilities

21.6%

29.6%

5.7%

Analyst Consensus

Recommendation3.00/5 Hold

Last price$26.81

Price target$26.00

Implied move-3.0%

Analysts2

ForecastQ Portfolios

LKFT is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.

Company Profile

Lakefront Biotherapeutics NV, formerly Galapagos NV, is a biotechnology company that focuses on transforming patient outcomes through scientific innovation. It is dedicated to building a pipeline of medicines for patients with serious diseases in therapeutic areas of unmet need, prioritizing oncology and immunology & inflammation programs. The company's clinical-stage portfolio is anchored by potential first-in-class treatments for autoimmune diseases.